Overview

Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate treatment in Gastroesophageal Reflux Disease (GERD) patients (aged 18~75) with endoscopically proven GERD treated with AGSPT201 Tablet.
Phase:
Phase 3
Details
Lead Sponsor:
Ahn-Gook Pharmaceuticals Co.,Ltd
Treatments:
Pantoprazole